Botanical species · safety record

Baileya multiradiata

The EFSA Compendium of Botanicals holds 5 constituent measurements for Baileya multiradiata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Baileya multiradiata Harv. & A.Gray ex Torr.

5Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Sesquiterpene lactones4
  • Hymenoxon1

Plant parts

  • Flower3
  • Aerial part of plants1
  • Leaves1

Preparations

  • Solvent extraction5

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Sesquiterpene lactonesFlowerSolvent extractionChromatographic testsResolve DOI
HymenoxonFlowerSolvent extraction0.28 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Sesquiterpene lactonesLeavesSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
Sesquiterpene lactonesFlowerSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Sesquiterpene lactonesAerial part of plantsSolvent extractionUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Pettit, G.R., Herald, C.L., Gust, D., Herald, D.L., Vanell, L.D. Antineoplastic agents. 55. Isolation and structure of multigilin and multistatin. Journal of Organic Chemistry, 1978, vol. 43, no. 6, p. 1092-1095.
  2. Hill, D.W., Kirn, H.L., Camp, B.J. Quantitative analysis of hymenoxon in plant tissue. Journal of Agricultural and Food Chemistry, 1979, vol. 27, no. 4, p. 885-887.
  3. Dominguez, X. A., Gutierrez, M., Aragon, R. Isolation of baileyolin a tumor inhibitory and antibiotic sesquiterpene lactone from Baileya multiradiata.. Planta Medica, 1976, vol. 30, no. 4, p. 356-9.
  4. Pettit, George R., Herald, Cherry L., Judd, Gerard F., Bolliger, George., Thayer, Philip S. Antineoplastic and cytotoxic components of desert Baileya.. Journal of Pharmaceutical Sciences, 1975, vol. 64, no. 12, p. 2023-4. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue